Oscar Health, Inc. Revenues
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2026-08-07
- Oscar Health, Inc. revenues for the quarter ending 2026-06-30 was $4.88B, a 70.40% increase year-over-year.
- Oscar Health, Inc. revenues for the quarter ending 2026-03-31 was $4.65B, a 52.55% increase year-over-year.
- Oscar Health, Inc. revenues for the quarter ending 2025-12-31 was $2.81B, a 17.25% increase year-over-year.
- Oscar Health, Inc. revenues for the quarter ending 2025-09-30 was $2.99B, a 23.21% increase year-over-year.
- Oscar Health, Inc. revenues for fiscal 2025 was $11.70B, a 27.50% increase from fiscal 2024.
- Oscar Health, Inc. revenues for fiscal 2024 was $9.18B, a 56.54% increase from fiscal 2023.
- Oscar Health, Inc. revenues for fiscal 2023 was $5.86B, a 47.92% increase from fiscal 2022.
- Oscar Health, Inc. revenues for fiscal 2022 was $3.96B, a 115.57% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.88B 10-Q · filed 2026-08-07 | $9.53B 10-Q · filed 2026-08-07 | $12.33B derived: sum of 3 quarters · filed 2026-08-07 | $15.32B derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $4.65B 10-Q · filed 2026-05-07 | $7.45B derived: sum of 2 quarters · filed 2026-05-07 | $10.44B derived: sum of 3 quarters · filed 2026-05-07 | $13.30B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.81B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $5.79B derived: sum of 2 quarters · filed 2026-02-13 | $8.66B derived: sum of 3 quarters · filed 2026-08-07 | $11.70B 10-K · filed 2026-02-13 |
| 2025-09-30 | $2.99B 10-Q · filed 2025-11-06 | $5.85B derived: sum of 2 quarters · filed 2026-08-07 | $8.90B 10-Q · filed 2025-11-06 | $11.29B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $2.86B 10-Q · filed 2026-08-07 | $5.91B 10-Q · filed 2026-08-07 | $8.30B derived: sum of 3 quarters · filed 2026-08-07 | $10.73B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $3.05B 10-Q · filed 2026-05-07 | $5.44B derived: sum of 2 quarters · filed 2026-05-07 | $7.86B derived: sum of 3 quarters · filed 2026-05-07 | $10.08B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.39B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $4.82B derived: sum of 2 quarters · filed 2026-02-13 | $7.04B derived: sum of 3 quarters · filed 2026-02-13 | $9.18B 10-K · filed 2026-02-13 |
| 2024-09-30 | $2.42B 10-Q · filed 2025-11-06 | $4.64B derived: sum of 2 quarters · filed 2025-11-06 | $6.79B 10-Q · filed 2025-11-06 | $8.22B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $2.22B 10-Q · filed 2025-08-07 | $4.36B 10-Q · filed 2025-08-07 | $5.79B derived: sum of 3 quarters · filed 2026-02-13 | $7.23B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $2.14B 10-Q · filed 2025-05-08 | $3.57B derived: sum of 2 quarters · filed 2026-02-13 | $5.01B derived: sum of 3 quarters · filed 2026-02-13 | $6.54B derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.87B derived: sum of 2 quarters · filed 2026-02-13 | $4.39B derived: sum of 3 quarters · filed 2026-02-13 | $5.86B 10-K · filed 2026-02-13 |
| 2023-09-30 | $1.44B 10-Q · filed 2024-11-07 | $2.96B derived: sum of 2 quarters · filed 2024-11-07 | $4.43B 10-Q · filed 2024-11-07 | $5.43B derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $1.52B 10-Q · filed 2024-08-07 | $2.99B 10-Q · filed 2024-08-07 | $3.99B derived: sum of 3 quarters · filed 2025-02-20 | $4.96B derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.47B 10-Q · filed 2024-05-07 | $2.46B derived: sum of 2 quarters · filed 2025-02-20 | $3.44B derived: sum of 3 quarters · filed 2025-02-20 | $4.46B derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $995.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.97B derived: sum of 2 quarters · filed 2025-02-20 | $2.99B derived: sum of 3 quarters · filed 2025-02-20 | $3.96B 10-K · filed 2025-02-20 |
| 2022-09-30 | $978.43M 10-Q · filed 2023-11-07 | $2.00B derived: sum of 2 quarters · filed 2023-11-07 | $2.97B 10-Q · filed 2023-11-07 | $3.46B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $1.02B 10-Q · filed 2023-08-09 | $1.99B 10-Q · filed 2023-08-09 | $2.49B derived: sum of 3 quarters · filed 2024-02-15 | $2.93B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $972.76M 10-Q · filed 2023-05-10 | $1.47B derived: sum of 2 quarters · filed 2024-02-15 | $1.91B derived: sum of 3 quarters · filed 2024-02-15 | $2.44B derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $496.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $940.05M derived: sum of 2 quarters · filed 2024-02-15 | $1.47B derived: sum of 3 quarters · filed 2024-02-15 | $1.84B 10-K · filed 2024-02-15 |
| 2021-09-30 | $443.98M 10-Q · filed 2022-11-09 | $973.26M derived: sum of 2 quarters · filed 2022-11-09 | $1.34B 10-Q · filed 2022-11-09 | $1.50B derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $529.28M 10-Q · filed 2022-08-12 | $898.67M 10-Q · filed 2022-08-12 | $1.06B derived: sum of 3 quarters · filed 2023-02-24 | $1.16B derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $369.39M 10-Q · filed 2022-05-12 | $527.06M derived: sum of 2 quarters · filed 2023-02-24 | $628.76M derived: sum of 3 quarters · filed 2023-02-24 | $744.09M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $157.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $259.37M derived: sum of 2 quarters · filed 2023-02-24 | $374.70M derived: sum of 3 quarters · filed 2023-02-24 | $462.80M 10-K · filed 2023-02-24 |
| 2020-09-30 | $101.70M 10-Q · filed 2021-11-12 | $217.03M derived: sum of 2 quarters · filed 2021-11-12 | $305.13M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $115.33M 10-Q · filed 2021-08-13 | $203.43M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $88.10M 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | $488.19M 10-K · filed 2022-02-25 |